Regional Covid-19 Resources and On Reserve Stats by Region Below:
Black = New Cases, Green = Recovered, Red = Deaths, Blue – Hospitalized, Purple – ISC reported total –  Updated Daily

BC
2 181 76 2,914 3,009
AB
29 437 80 7,651 8,132
SK
17 186 61 6,597 6,759
MB
52 366 76 7,287 7,570
ON
8 78 30 1,901 2,012
QC
0 14 5 702 728
Atlantic
0 0 0 10 16
North60
20 13 6 658 796
 

Widgetized Section

Go to Admin » Appearance » Widgets » and move Gabfire Widget: Social into that MastheadOverlay zone

Not available in Canada: A look at COVID-19 vaccine tech from China, India and Cuba – CBC

Inactivated, conjugate COVID-19 vaccines developed, in use in middle-income countries

May 04, 2021

COVID-19 vaccines developed in China are already being used in several countries around the world. And some developed in India, Kazakhstan and Cuba have been in use domestically for their own populations even before completion of Phase 3 trials.

Vaccines being made in some of those countries (including the Serum Institute of India’s Covishield version of the AstraZeneca vaccine) use the viral vector technology or mRNA technologies used to inoculate Canadians. But other vaccines developed domestically are quite different.

Here’s a closer look at two kinds of COVID-19 vaccines —inactivated and conjugate protein vaccines — developed in middle-income countries and not available in Canada.

Read more: https://www.cbc.ca/news/science/inactivated-conjugate-covid-19-vaccines-1.6011962

NationTalk Partners & Sponsors Learn More